Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANA4CKD
2024-514347-28-00Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gout and chronic kidney disease (CKD) comparing Anakinra arm with Prednisone arm (2 arms). Started Oct 2024; status: completed.
02
Drugs
anakinraprednisone
03
Conditions
goutchronic kidney disease (CKD)
Beyond the preview
Go deeper on 2024-514347-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514347-28-00.